DIABDefence Industry Advisory Board (Australia)
DIABDepartmental Items Adjustments and Borrowings (Department of Foreign Affairs and Trade; Australia)
References in periodicals archive ?
I am pleased to announce that our GMP facility has been expanded with the lease of additional manufacturing space for DIAB II production.
all patent rights for use of DIAB II that arise from this new patent .
We are very pleased that DIAB II has received full approval for sale in Peru as a prescription treatment for Type II Diabetes.
This is an important step in bringing DIAB II to one of the largest and fastest-growing pharmaceutical markets in the world.
In Mexico, we expect to file a DIAB II registration dossier in the next 30 days and project an approval in the first half of 2002.
In exchange for Immunis' interest in DIAB II, Biotech Holdings has agreed to issue, to Immunis Corp.
Rieveley said that additional safety information is being provided about DIAB II, which is not a glitazone.
Bilim's very extensive manufacturing experience may also prove important for expediting the supply of DIAB II to the Turkish market and to some of the export markets into which Bilim regularly sells pharmaceutical products," Mr.
In Brazil, our Registration Dossier for DIAB II has been in the hands of our licensee since March.
We believe that the extensive regulatory experience that Micrometrix brings to our partnership will be invaluable for guiding our DIAB II regulatory application and that our partner's manufacturing capabilities will enhance our prospects for a timely launch of DIAB II in Mexico," Rieveley said.
to submit their application to have DIAB II approved for sale in the Brazilian market, a leading drug market in Latin America.
s (OTC Bulletin Board: IMMC) President, Colin Leech-Porter, announced today that the specialized controlled-environmental area for the production of DIAB II at Biotech Holdings Ltd.